HHS and NIH take steps to enhance transparency of clinical trial results

The US National Institutes of Health has proposed a new policy to promote the sharing of findings from clinical trials that it funds. The results of clinical trials are often not disclosed in a timely fashion, if at all. The new rule they propose will require investigators funded by NIH to register their clinical trial and submit summary results, including adverse event information, to ClinicalTrials.gov. This proposal goes further, they say, than the new Department of Health and Human Services rule that summary data from clinical trials of drugs and devices regulated by the Food and Drug Administration, including failed trials, must be publicly shared.

Source: https://www.genomeweb.com/scan/and-result?utm_source=SilverpopMailing&utm_medium=email&utm_campaign=Scan%20Blog%3A%20New%20Clinical%20Trial%20Reporting%20Rule%20Proposed%2C%20This%20Week%27s%20Nature%2C%20Relationship%20Variant%2C%20more%20-%2011/20/2014%2001%3A00%3A00%20PM